GeoVax Labs Inc.

(NASDAQ:GOVX) Trade

Symbol has changed to a new ticker symbol

(GOVXD)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Geovax Labs Inc is US-based clinical-stage biotechnology company. It is engaged in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) vector vaccine platform. The development programs of the company focused on preventive vaccines against Human Immunodeficiency Virus (HIV), Zika Virus, hemorrhagic fever viruses, and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The product pipeline includes HIV-Clade B Preventive Vaccine, HIV-Clade B Immunotherapy, Hemorrhagic Fever Vaccines, Zika Vaccine, Malaria vaccine, and Cancer Immunotherapy.

Contact Information

Website: www.geovax.com
Email: investor@geovax.com
Main Phone: +1 678 384-7220
Address: 1900 Lake Park Drive
Address 2: Suite 380
State: GA
City / Town: Smyrna
Country: US
Postal Code: 30080

Issuer Information

Exchange: NSC
CEO: David A. Dodd
Employees: 7
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A